Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial

Dellapasqua, Silvia; Gray, Kathryn P.; Munzone, Elisabetta; Rubino, Daniela; Gianni, Lorenzo; Johansson, Harriet; Viale, Giuseppe; Ribi, Karin; Bernhard, Jürg; Kammler, Roswitha; Maibach, Rudolf; Rabaglio, Manuela; Ruepp, Barbara; Di Leo, Angelo; Coates, Alan S.; Gelber, Richard D.; Regan, Meredith M.; Goldhirsch, Aron; Colleoni, Marco (2019). Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial. Journal of clinical oncology, 37(5), pp. 386-395. American Society of Clinical Oncology 10.1200/JCO.18.00296

[img]
Preview
Text
370_Dellapasqua_TREND_JCO_2018 (1).pdf - Published Version
Available under License Publisher holds Copyright.

Download (1MB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Bernhard, Jürg Theodor, Rabaglio, Manuela Elena

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0732-183X

Publisher:

American Society of Clinical Oncology

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

28 Mar 2019 12:17

Last Modified:

02 Mar 2023 23:31

Publisher DOI:

10.1200/JCO.18.00296

PubMed ID:

30589600

BORIS DOI:

10.7892/boris.124915

URI:

https://boris.unibe.ch/id/eprint/124915

Actions (login required)

Edit item Edit item
Provide Feedback